Cargando…
The activation fragment of PAR2 is elevated in serum from patients with rheumatoid arthritis and reduced in response to anti-IL6R treatment
Osteoarthritis (OA) and rheumatoid arthritis (RA) are serious and painful diseases. Protease-activated receptor 2 (PAR2) is involved in the pathology of both OA and RA including roles in synovial hyperplasia, cartilage destruction, osteophyogenesis and pain. PAR2 is activated via cleavage of its N-t...
Autores principales: | Kalogera, Stefania, He, Yi, Bay-Jensen, Anne-Christine, Gantzel, Thorbjørn, Sun, Shu, Manon-Jensen, Tina, Karsdal, Morten Asser, Thudium, Christian S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688421/ https://www.ncbi.nlm.nih.gov/pubmed/34930943 http://dx.doi.org/10.1038/s41598-021-03346-0 |
Ejemplares similares
-
Neo-Epitopes—Fragments of Cartilage and Connective Tissue Degradation in Early Rheumatoid Arthritis and Unclassified Arthritis
por: Maijer, Karen I., et al.
Publicado: (2016) -
Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis
por: Kjelgaard‐Petersen, Cecilie F., et al.
Publicado: (2018) -
A Highly Sensitive Biomarker of Type II Collagen C-Terminal Pro-Peptide Associated with Cartilage Formation
por: Port, Helena, et al.
Publicado: (2022) -
Relevance of Biomarkers in Serum vs. Synovial Fluid in Patients with Knee Osteoarthritis
por: Kalogera, Stefania, et al.
Publicado: (2023) -
The Janus kinase 1/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis
por: Thudium, Christian S., et al.
Publicado: (2020)